Status:
COMPLETED
BEAST: A Pilot Trial
Lead Sponsor:
VA Office of Research and Development
Conditions:
Anxiety Sensitivity
Functional Impairment
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This pilot study trial will test the acceptability, feasibility, and usability of a brief enhanced anxiety sensitivity treatment to reduce anxiety sensitivity and functional impairment in Veterans.
Detailed Description
This study tests a treatment with two components: first, there is a single session face-to-face virtual intervention delivered by the counselor or therapist via VA Video Connect software. Second, a mo...
Eligibility Criteria
Inclusion
- Are English-speaking
- Score equal to or greater than 9 on the SSASI indicating elevated anxiety sensitivity
- Score equal to or greater than 5 on the WHODAS 2.0
Exclusion
- Veterans with cognitive impairment as measured scoring equal to or greater than 11 on the Blessed
- Orientation-Memory-Concentration Test
- Veterans without access to a smartphone
- Veterans with significant medical or psychiatric conditions that may limit participation, including:
- severe documented schizophrenia
- an ongoing active psychotic or manic state
- an imminent suicide crisis will be excluded from our study and provided the appropriate referral
Key Trial Info
Start Date :
September 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 30 2024
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT05416203
Start Date
September 1 2022
End Date
August 30 2024
Last Update
July 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Finger Lakes Healthcare System, Canandaigua, NY
Canandaigua, New York, United States, 14424-1159